Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/11/2007WO2007115071A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
10/11/2007WO2007115058A2 Thiadiazolidinone inhibitors of ptpase
10/11/2007WO2007115020A2 Therapeutic prostaglandin compounds for the treatment of glaucoma
10/11/2007WO2007115001A1 Prostaglandin ep4 agonists
10/11/2007WO2007114952A2 Data exchange systems and methods employing rf data transmission
10/11/2007WO2007114951A2 Apparatus, system, and/or method for protection and control of an electrical device
10/11/2007WO2007114949A2 Securing apparatus and method
10/11/2007WO2007114945A2 Compositions and methods for enhancing the antioxidant status of animals
10/11/2007WO2007114932A2 Search system and method with text function tagging
10/11/2007WO2007114931A2 Nanoelectronic detection of biomolecules employing analyte amplification and reporters
10/11/2007WO2007114930A2 Secure test-for-yield chip diagnostics management system and method
10/11/2007WO2007114922A2 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
10/11/2007WO2007114920A2 Fungo batting assistance machine
10/11/2007WO2007114907A2 Variable capacity air conditioning system
10/11/2007WO2007114903A2 Treatments using citrulline
10/11/2007WO2007114855A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/11/2007WO2007114852A2 Materials having an enhanced emissivity and methods for making the same
10/11/2007WO2007114849A2 Activated carbon from carbohydrate
10/11/2007WO2007114843A2 Light activated antiviral materials and devices and methods for decontaminating virus infected environments
10/11/2007WO2007114827A1 Substituted heterocyclic compounds and methods of use
10/11/2007WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007WO2007114771A1 2-AMINOPYRIMIDIN-4-ONES AND THEIR USE FOR TREATING OR PREVENTING Aβ-RELATED PATHOLOGIES
10/11/2007WO2007114770A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
10/11/2007WO2007114763A1 Sulphonamide derivates as modulators of the glucocorticoid receptor
10/11/2007WO2007114697A1 Novel composition for tumor growth control
10/11/2007WO2007114696A1 Milk oligosaccharides for stimulating the immune system
10/11/2007WO2007114683A1 Milk oligosaccharides for stimulating the immune system
10/11/2007WO2007114540A1 Methods for modulating the development of dopamine neuron by the dopamine d2 receptor and compositions thereof
10/11/2007WO2007114534A1 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound
10/11/2007WO2007114526A1 Process for producing high-purity prasugrel and acid addition salt thereof
10/11/2007WO2007114499A1 Anti-fat-accumulation composition
10/11/2007WO2007114475A1 Cocrystal of c-glycoside derivative and l-proline
10/11/2007WO2007114461A1 Process for production of carotenoid
10/11/2007WO2007114380A1 Agent for external application to the skin
10/11/2007WO2007114376A1 Solid pharmaceutical preparation
10/11/2007WO2007114338A1 Acid secretion inhibitor
10/11/2007WO2007114326A1 Novel compound having heterocyclic ring
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114315A1 Therapeutic agent for corneal/conjunctival disorder
10/11/2007WO2007114300A1 Preservative agent
10/11/2007WO2007114239A1 ANTI-CANCER AGENT COMPRISING DGKα INHIBITOR
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007114199A1 Process for producing optically active (s)-7-hydroxy-6-methylheptane-2-one and precursor thereof
10/11/2007WO2007114128A1 Method for production of capsinoid-containing beverage/food
10/11/2007WO2007114124A1 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11β-HYDROXYSTEROID DEHYDROGENASE TYPE I
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113885A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/11/2007WO2007113857A2 Modified release clopidogrel formulation
10/11/2007WO2007113841A2 Novel aminoglycosides and uses thereof in the treatment of genetic disorders
10/11/2007WO2007113835A1 Anti-allergy compositions
10/11/2007WO2007113831A2 Infant treatment apparatus
10/11/2007WO2007113830A2 Kit for treating skin infection
10/11/2007WO2007113826A2 Hydrophobic formulations
10/11/2007WO2007113748A1 Oral formulation with beneficial cardiovascular effects, comprising berberine
10/11/2007WO2007113680A2 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
10/11/2007WO2007113671A1 Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007WO2007113650A2 A novel and improved process fro the preparation of nateglinide and its polymorph form-h
10/11/2007WO2007113647A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4υl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007WO2007113596A1 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
10/11/2007WO2007113575A2 Reagents and methods for cross-linking biological molecules
10/11/2007WO2007113565A1 Naphthyridine derivatives as anti-cancer agents
10/11/2007WO2007113557A1 Substituted quinazolines with anti-cancer activity
10/11/2007WO2007113548A1 Naphthyridine derivatives
10/11/2007WO2007113540A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle
10/11/2007WO2007113538A1 Substituted adenines and the uses thereof
10/11/2007WO2007113536A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007WO2007113454A1 Particulate compositions comprising alginate and/or alginic acid
10/11/2007WO2007113371A1 Pharmaceutical composition and preparation method thereof
10/11/2007WO2007113309A2 Compounds which inhibit the glycine transporter and uses thereof
10/11/2007WO2007113290A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
10/11/2007WO2007113289A1 Benzofuran compounds as ep1 receptor antagonists
10/11/2007WO2007113276A1 Novel bi-aryl amines
10/11/2007WO2007113270A1 15-o-desmethylmacbecin derivatives and their use in the treatment of cancer or b-cell malignancies
10/11/2007WO2007113269A2 15-desmethoxymacbecin derivatives for the treatment of cancer diseases
10/11/2007WO2007113268A1 4, 5-dihydromacbecin derivatives and their use in the treatment of cancer or b-cell malignancies.
10/11/2007WO2007113260A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113258A1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113256A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007WO2007113254A1 Hiv inhibiting 5-amido substituted pyrimidines
10/11/2007WO2007113249A2 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
10/11/2007WO2007113246A1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
10/11/2007WO2007113245A1 Thiazolyl dihydro-indazoles
10/11/2007WO2007113243A2 Use of pde 5 inhibitors for the treatment of overactive bladder
10/11/2007WO2007113232A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113226A1 Organic compounds
10/11/2007WO2007113212A2 Use of a kinase inhibitor for the treatment of particular resistant tumors
10/11/2007WO2007113202A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
10/11/2007WO2007113198A2 Use of a kinase inhibitor for the treatment of particular resistant tumors
10/11/2007WO2007113170A1 Use of strobilurins for treating malfunctions of the iron metabolism
10/11/2007WO2007113159A1 3',5'-di-o-acylated nucleosides for hcv treatment
10/11/2007WO2007113153A1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
10/11/2007WO2007113005A2 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors
10/11/2007WO2007113000A1 3-SUBSTITUTED N-(ARYL- OR HETEROARYL)-PYRAZO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS
10/11/2007WO2007112998A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori [1,5-a]pyrimidines as kinase inhibitors
10/11/2007WO2007112986A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007WO2007112968A2 Anti-inflammatory polymer
10/11/2007WO2007112966A1 Cellulose sulfate for the treatment of rhinovirus infection
10/11/2007WO2007112964A1 Novel use of ascorbigen
10/11/2007WO2007112963A1 Novel use of ascorbigen
1 ... 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 ... 7860